Journey Medical

DERM · NASDAQ

$5.22+$0.05 (+0.97%)TodayMarket closed · Oct 20, 6:05 PM ET

Prev close $5.17

Latest news

Press releaseSep 8, 4:05 PM ETGlobe Newswire
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Press releaseAug 19, 4:05 PM ETGlobe Newswire
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
NewsAug 13, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseAug 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseAug 5, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
NewsMay 13, 5:17 PM ET
Transcript: Journey Medical Q1 2026 Earnings Conference Call
Press releaseMay 13, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
Press releaseMay 6, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
Press releaseApr 30, 10:40 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
Press releaseApr 28, 4:57 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
Press releaseApr 14, 4:49 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
Press releaseApr 9, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
NewsMar 26, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 25, 4:20 PM ET
Journey Medical Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $16.079M Miss $18.863M Estimate
Press releaseMar 25, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
NewsMar 25, 7:11 AM ET
Earnings Scheduled For March 25, 2026
Press releaseMar 18, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
NewsNov 12, 4:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseNov 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
NewsNov 12, 6:11 AM ET
Earnings Scheduled For November 12, 2025
NewsNov 11, 1:03 PM ET
Insights into Journey Medical's Upcoming Earnings
Press releaseNov 5, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
NewsAug 13, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 13, 8:35 AM ETAvi Kapoor
CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
NewsAug 13, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsAug 13, 7:17 AM ETAvi Kapoor
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
NewsAug 12, 5:07 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseAug 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseAug 5, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
Press releaseJun 9, 8:30 AM ETGlobe Newswire
Journey Medical Corporation Announces Emrosi™ Featured on "The Balancing Act" Airing on Lifetime TV
Press releaseMay 15, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseMay 14, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseMay 7, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Press releaseApr 1, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
Press releaseMar 31, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Press releaseMar 26, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
Press releaseMar 24, 8:30 AM ETGlobe Newswire
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Press releaseMar 19, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
Press releaseMar 12, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
Press releaseMar 5, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
Press releaseMar 4, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
Press releaseNov 14, 4:10 PM ETGlobe Newswire
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Press releaseAug 13, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Journey Medical Corporation to Participate in September 2026 Investor Conferences

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Transcript: Journey Medical Q1 2026 Earnings Conference Call

Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Earnings Scheduled For May 13, 2026

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

12 Health Care Stocks Moving In Thursday's Intraday Session

Journey Medical Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $16.079M Miss $18.863M Estimate

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Earnings Scheduled For March 25, 2026

Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Earnings Scheduled For November 12, 2025

Insights into Journey Medical's Upcoming Earnings

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session

CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Tuesday's After-Market Session

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation Announces Emrosi™ Featured on "The Balancing Act" Airing on Lifetime TV

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights